BayMedica

#Rare #Cannabinoid manufacturer, division of @InMedPharma. B2B supplier of d9 #THCV #CBC #CBDV #CBT #cannabinoids for the health and wellness industry.

[InMed Pharmaceuticals @inmedpharma]

What have we learned about #Alzheimer’s over the last five years? What are the next developments?

#AlzheimersDisease experts Dr. @PhylFerrell of @startuphealth #AlzMoonshot, Dr. David Morgan of @michiganstateu, @MarwanSabbaghMD of @BarrowNeuro, Dr. Barry Greenberg of @JohnsHopkins
School of Medicine, and Dr. Eric Hsu of @inmedpharma come together on Nov 12th in a @FierceBiotech #webinar to talk about the latest #Alzheimers research and the effects of #neuroinflammation.

Register FREE: https://t.co/44m4NTAsZu

$INM

[InMed Pharmaceuticals @inmedpharma]

#Alzheimer's disease leaders to discuss research breakthroughs, therapeutic pathways & effects of #neuroinflammation in #Alzheimers.

Join Dr. Phyllis Ferrell, Dr. Marwan Sabbagh, Dr. Barry Greenberg, Dr. David Morgan and Dr. Eric Hsu on Nov 12th.

https://t.co/MAPmXaup7b

$INM

[InMed Pharmaceuticals @inmedpharma]

InMed's Dr. Eric Hsu is a guest columnist for Drug Discovery Online.
"#Cannabinoids Show Promise As New Treatment For #Alzheimer's Disease" explores #Alzheimers pathologies, #neuroinflammation, current treatments & restoring #neuronal function.

https://t.co/yzQSdhDrmZ

$INM

[BayMedica @BayMedica]

Come visit us at #mjbizcon this week! Ask us about our #bioidentical rare #cannabinoids . We're at booth 7638!

#mjbizcon2023

[InMed Pharmaceuticals @inmedpharma]

How do #cannabinoids interact with the body’s #endocannabinoid system? Dr. Shane Johnson talks about the important role the #EndocannabinoidSystem has in maintaining #homeostasis.

Watch video: https://t.co/VZsyxAySRm

$INM #cannabinoidscience

[BayMedica @BayMedica]

BayMedica’s Jerry Griffin joins this @Benzinga panel discussion to talk about the growing #cannabinoid industry and how CPG companies are creating innovative products with #rarecannabinoid ingredients.

Watch: https://t.co/BgjBhEc5Xd

$INM #rarecannabinoids #productinnovation

[BayMedica @BayMedica]

#ICYMI Dr Shane Johnson joins Water Tower Hour #podcast @JesseRedmond to talk #rarecannabinoids, the market opportunity, importance of #cannabinoid consistency for CPG products & the challenges of the current #cannabinoids landscape.

Listen here: https://t.co/RgSp7VC7Lp

$INM

[InMed Pharmaceuticals @inmedpharma]

What makes #cannabinoids an interesting pharmaceutical target?

#Cannabinoids interact with the body's endocannabinoid system & may help with the maintenance of our well-being.

Dr. Shane Johnson of @BayMedica explains: https://t.co/wfqfyHlsSN

$INM #rarecannabinoids

[InMed Pharmaceuticals @inmedpharma]

Dr. Shane Johnson at InMed's subsidiary @BayMedica gives examples of common consumer products that use bioidentical synthesized compounds.

Watch video: https://t.co/RGGeM1Ig6P

$INM #rarecannabinoids #cannabinoids

[InMed Pharmaceuticals @inmedpharma]

Today 2pm @BayMedica’s Jerry Griffin will join Robert Sassoon of @WTR_Research for a Fireside Chat where they'll discuss the market dynamics and disruptive potential of rare #cannabinoids and upcoming catalysts for #BayMedica. $inm

Register: https://t.co/czj8F00rQZ

[InMed Pharmaceuticals @inmedpharma]

InMed provides update on subsidiary @BayMedica

“We attribute the increasing demand, in part, to better research of rare #cannabinoids…and the ability of companies like ours to be able to reliably supply high quality rare cannabinoids.”

https://t.co/SsDvEDxf2K

$INM

[InMed Pharmaceuticals @inmedpharma]

InMed provides a commercial update subsidiary @BayMedica

“We have seen demand for rare #cannabinoids surge over the past year, and we are pleased to have been able to increase production to meet the needs of our customers…”

https://t.co/eEyYjvxonC

$INM #cannabinoidsupplier

[InMed Pharmaceuticals @inmedpharma]

InMed Provides Update on @BayMedica Rare #Cannabinoid Business

“We are very encouraged to see another strong quarter with revenues (unaudited) in excess of $2.3M, representing our third consecutive quarter with significant revenue growth…”

More: https://t.co/kBh1mMvYhB

$INM

[InMed Pharmaceuticals @inmedpharma]

InMed today provided a commercial and manufacturing update on its subsidiary @BayMedica a leading supplier of #bioidentical rare #cannabinoids to the Health and Wellness market.

Read news: https://t.co/fvKL0PmzZV

$INM #cannabinoidsupplier

[InMed Pharmaceuticals @inmedpharma]

InMed Provides Update on BayMedica Rare Cannabinoid Business

•$2.3M revenues (unaudited) in Q4 2023, representing 123% increase QoQ
•3rd consecutive quarter with significant revenue growth

More: https://t.co/RUbkjhWZmx

$INM #cannabinoids

[InMed Pharmaceuticals @inmedpharma]

What are the different cannabinoid formulation techniques used in CPG products?

@BayMedica's Shane Johnson explains what precise ratio & enhanced formulation mean & its importance in formulating #cannabinoid products.

https://t.co/6QwO832Zsq

$INM #cannabinoids #preciseratio

[InMed Pharmaceuticals @inmedpharma]

Our subsidiary, @BayMedica, manufactures #bioidentical rare #cannabinoids. Our rare #cannabinoids #CBC, #THCV, #CBDV and #CBT have been manufactured at commercial scale ensuring purity and batch-to-batch consistency.

https://t.co/wRI5bgSKT6

$INM

[InMed Pharmaceuticals @inmedpharma]

What is THCV?

#THCV is non-intoxicating rare #cannabinoid that has been researched for a variety of physiological benefits, most notably for its appetite suppressing effects. InMed's subsidiary @BayMedica manufactures bioidentical THCV.

https://t.co/yJayAHlPWE

$INM

[InMed Pharmaceuticals @inmedpharma]

#Cannabinoids innately interact with the body's #endocannabinoid system.

#Cannabinoid receptors are found throughout the body and are involved in many different functions, such as pain perception, memory, immune function and sleep.

More: https://t.co/VL2m6m783i

$INM

[InMed Pharmaceuticals @inmedpharma]

Webcast replay: Addressing the Increasing Demand for Rare Cannabinoids

InMed’s Eric Adams & Jerry Griffin talk about the commercial opportunity of rare #cannabinoids, their use in different products & potential for therapeutic development.

Watch: https://t.co/RcSQWrE8Bw

$INM